Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CORAL LAB.   MYLAN
EQUITY SHARE DATA
    CORAL LAB.
Mar-23
MYLAN
Dec-18
CORAL LAB./
MYLAN
5-Yr Chart
Click to enlarge
High Rs3683,975-   
Low Rs2172,188-   
Sales per share (Unadj.) Rs218.81,829.1-  
Earnings per share (Unadj.) Rs18.149.7-  
Cash flow per share (Unadj.) Rs24.2392.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs433.61,978.8-  
Shares outstanding (eoy) m3.57514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 79.4%   
Avg P/E ratio x16.262.0 26.1%  
P/CF ratio (eoy) x12.17.9 154.2%  
Price / Book Value ratio x0.71.6 43.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,0451,585,442 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1110-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m781941,074 0.1%  
Other income Rs m690-   
Total revenues Rs m850941,074 0.1%   
Gross profit Rs m39243,515 0.0%  
Depreciation Rs m22176,206 0.0%   
Interest Rs m345,262 0.0%   
Profit before tax Rs m8222,047 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m18-3,507 -0.5%   
Profit after tax Rs m6425,554 0.3%  
Gross profit margin %4.925.9 19.0%  
Effective tax rate %21.6-15.9 -136.1%   
Net profit margin %8.32.7 303.8%  
BALANCE SHEET DATA
Current assets Rs m1,235525,495 0.2%   
Current liabilities Rs m119383,144 0.0%   
Net working cap to sales %143.015.1 945.1%  
Current ratio x10.41.4 759.5%  
Inventory Days Days23184 276.3%  
Debtors Days Days1,09493 1,172.7%  
Net fixed assets Rs m508182,553 0.3%   
Share capital Rs m36501 7.1%   
"Free" reserves Rs m1,5120-   
Net worth Rs m1,5481,018,070 0.2%   
Long term debt Rs m01,098,825 0.0%   
Total assets Rs m1,7432,730,861 0.1%  
Interest coverage x25.31.5 1,699.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.40.3 130.0%   
Return on assets %3.92.6 150.0%  
Return on equity %4.22.5 165.9%  
Return on capital %5.53.2 174.0%  
Exports to sales %92.10-   
Imports to sales %00-   
Net fx Rs m7060-   
CASH FLOW
From Operations Rs m127195,555 0.1%  
From Investments Rs m-26-101,081 0.0%  
From Financial Activity Rs m-64-91,101 0.1%  
Net Cashflow Rs m361,620 2.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare CORAL LAB. With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CORAL LAB. With: ZIM LABORATORIES  ZENOTECH LABS  VEERHEALTH CARE  IOL CHEMICALS & PHARM.  AARTI PHARMALABS  



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.